These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 18784172)

  • 1. Uganda to treat more people infected with HIV with antiretrovirals.
    Wasswa H
    BMJ; 2008 Sep; 337():a1610. PubMed ID: 18784172
    [No Abstract]   [Full Text] [Related]  

  • 2. Depression and CD4 cell count among persons with HIV infection in Uganda.
    Kaharuza FM; Bunnell R; Moss S; Purcell DW; Bikaako-Kajura W; Wamai N; Downing R; Solberg P; Coutinho A; Mermin J
    AIDS Behav; 2006 Jul; 10(4 Suppl):S105-11. PubMed ID: 16802195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
    Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
    Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence and treatment response among HIV-1-infected adults receiving antiretroviral therapy in a rural government hospital in Southwestern Uganda.
    Bajunirwe F; Arts EJ; Tisch DJ; King CH; Debanne SM; Sethi AK
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(2):139-47. PubMed ID: 19258526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda.
    Bikaako-Kajura W; Luyirika E; Purcell DW; Downing J; Kaharuza F; Mermin J; Malamba S; Bunnell R
    AIDS Behav; 2006 Jul; 10(4 Suppl):S85-93. PubMed ID: 16791525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV patients taking antiretrovirals should avoid garlic, St. John's wort. Other health products were fine.
    AIDS Alert; 2006 Feb; 21(2):21-2. PubMed ID: 16562338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uganda leads way in innovative HIV/AIDS treatment.
    Wendo C
    Bull World Health Organ; 2005 Apr; 83(4):244-5. PubMed ID: 15868011
    [No Abstract]   [Full Text] [Related]  

  • 8. Ugandan hospitals ration AIDS treatment as antiretrovirals start to run out.
    Wasswa H
    BMJ; 2010 Jul; 341():c3900. PubMed ID: 20647289
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs for the developing world.
    GMHC Treat Issues; 1997-1998 Winter; 12(1):32. PubMed ID: 11364989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
    Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
    Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glaxo Wellcome, Germany, spends 60.000 DM for African HIV projects in Uganda and Malawi].
    Krankenpfl J; 1999 Dec; 37(12):479. PubMed ID: 10734858
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiretroviral therapy in sub-Saharan Africa: myth or reality?
    Kebba A
    J Antimicrob Chemother; 2003 Nov; 52(5):747-9. PubMed ID: 14563895
    [No Abstract]   [Full Text] [Related]  

  • 13. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda.
    Gasasira AF; Kamya MR; Achan J; Mebrahtu T; Kalyango JN; Ruel T; Charlebois E; Staedke SG; Kekitiinwa A; Rosenthal PJ; Havlir D; Dorsey G
    Clin Infect Dis; 2008 Apr; 46(7):985-91. PubMed ID: 18444813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gift of hope to people with HIV.
    Snow T
    Nurs Stand; 2009 Aug 26-Sep 1; 23(51):22-3. PubMed ID: 19753773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What is the correct way to use protease inhibitors?].
    Agosto M
    Sidahora; 1996; ():33-5. PubMed ID: 11364293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda.
    Marseille E; Saba J; Muyingo S; Kahn JG
    AIDS; 2006 Apr; 20(6):907-14. PubMed ID: 16549976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS, HIV, antiretrovirals and Africa.
    Gazzard B
    J HIV Ther; 2006 Mar; 11(1):4-6. PubMed ID: 16706248
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of depression in predicting antiretroviral adherence in Ugandan parents and their children initiating HAART in the MTCT-plus family treatment model: commentary on Jayne Byakika-Tusiime et al. 2009.
    Nakimuli-Mpungu E; Musisi S
    AIDS Behav; 2009 Oct; 13(5):969-72. PubMed ID: 19662522
    [No Abstract]   [Full Text] [Related]  

  • 19. Tenofovir-associated kidney diseases and interactions between tenofovir and other antiretrovirals.
    Lanzafame M; Lattuada E; Rapagna F; Gottardi M; Vento S
    Clin Infect Dis; 2006 Jun; 42(11):1656-7; author reply 1658. PubMed ID: 16652329
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical illness as a marker for initiation of HIV antiretroviral therapy in a rural setting, Rakai, Uganda.
    Spacek LA; Gray RH; Wawer MJ; Sewankambo NK; Serwadda D; Wabwire-Mangen F; Kiwanuka N; Kigozi G; Nalugoda F; Quinn TC;
    Int J STD AIDS; 2006 Feb; 17(2):116-20. PubMed ID: 16464274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.